A detailed history of Superstring Capital Management LP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Superstring Capital Management LP holds 88,980 shares of OCUL stock, worth $988,567. This represents 0.98% of its overall portfolio holdings.

Number of Shares
88,980
Previous 42,297 110.37%
Holding current value
$988,567
Previous $310 Million 166.33%
% of portfolio
0.98%
Previous 0.37%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$6.02 - $9.46 $281,031 - $441,621
46,683 Added 110.37%
88,980 $826 Million
Q1 2025

May 15, 2025

BUY
$5.93 - $9.08 $250,821 - $384,056
42,297 New
42,297 $310 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $855M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Superstring Capital Management LP Portfolio

Follow Superstring Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Superstring Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Superstring Capital Management LP with notifications on news.